Cell line · CVCL_0178
BT-20
Cancer cell line, Homo sapiens. Invasive breast carcinoma of no special type. 88 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. BT-20. Cell lines, record CVCL_0178. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0178
On this page
Cell line
As Cellosaurus gives it.
- Name
- BT-20
- Accession
- CVCL_0178
- RRID
- RRID:CVCL_0178
- Synonyms
- BT 20, BT20
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 74Y
- Category
- Cancer cell line
- Diseases
- Invasive breast carcinoma of no special type (NCIt C4194)
- Derived from
- Breast (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers88
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of HOX/PBX Dimers as a Potential Therapeutic Strategy in Breast Cancer Subtypes Including Triple Negative Breast Cancer. | Curr Issues Mol Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor-educated macrophages promote cytokine-driven lung colonization in triple-negative breast cancer. | Oncoimmunology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TSPYL5 Promotes Triple-Negative Breast Cancer Metastasis by Antagonizing USP10-Mediated PTEN Stabilization to Unleash a ZEB1-Dependent EMT Program. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Discovery of novel circular RNAs of the apoptosis-related BAX gene in breast cancer, by combining nanopore and next-generation sequencing. | Mol Genet Genomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| COMP-PMEPA1 axis promotes epithelial-to-mesenchymal transition in breast cancer cells. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 88
See all 88 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | BT-20/CMV-Luc | CVCL_J244 | Cell lines | |
| Derived from it | BT-20/nKR | CVCL_M061 | Cell lines | |
| Derived from it | BT-20N | CVCL_F0XP | Cell lines |
Cell banks9
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8959 | ABM | |
| ATCC | CRL-7912 | Discontinued | Cellosaurus |
| ATCC | HTB-19 | ATCC | |
| AddexBio | C0006014/4910 | Cellosaurus | |
| CLS | 300130 | CLS | |
| Hysigen | TCH-C590 | Hysigen | |
| IBRC | C10149 | Cellosaurus | |
| KCLB | 60061 | KCLB | |
| NCBI_Iran | C434 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0178
GET https://conductscience.org/api/cell-lines/v1/CVCL_0178/papers?page=2